Month: September 2021

The Sperling Prostate Center is pleased to join seven academic centers in announcing the results of our national clinical trial of a novel focal prostate cancer treatment. keep reading

Dr. J. Curtis Nickel is a Canadian urologist who is an authority on prostate inflammation and BPH. In January, 2018 he opened his presentation to an audience of urologists and oncologists with the wry observation, keep reading

It has been, and continues to be, our position that metal instruments such as a scalpel or a biopsy needle are extremely unlikely to unleash PCa tumor cells that ultimately threaten a patient’s life. The predominant opinion among clinical professionals is that, even if it were to occur, it would be exceedingly rare. Another way to come at the prostatectomy-spreading-PCa problem is to broaden the question: can surgical removal of cancer cause the cancer to spread? keep reading

Did you ever take one of those whirlwind bus tours of Europe as a way to survey the best tourist attractions? Your itinerary might start by landing in London, then moving on to The Netherlands, Germany, Switzerland, Austria and Italy before your homeward bound departure. A July, 2021 published paper by Rakauskas, et al.[i] is keep reading